DK1418905T3 - Terapeutisk middel til depletering af en uönsket proteinpopulation fra plasma - Google Patents
Terapeutisk middel til depletering af en uönsket proteinpopulation fra plasmaInfo
- Publication number
- DK1418905T3 DK1418905T3 DK02751356T DK02751356T DK1418905T3 DK 1418905 T3 DK1418905 T3 DK 1418905T3 DK 02751356 T DK02751356 T DK 02751356T DK 02751356 T DK02751356 T DK 02751356T DK 1418905 T3 DK1418905 T3 DK 1418905T3
- Authority
- DK
- Denmark
- Prior art keywords
- depleting
- therapeutic agent
- plasma protein
- protein population
- unwanted plasma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0119370.5A GB0119370D0 (en) | 2001-08-08 | 2001-08-08 | Therapeutic agent |
US09/985,699 US7045499B2 (en) | 2001-08-08 | 2001-11-05 | Therapeutic agent |
PCT/GB2002/003504 WO2003013508A1 (en) | 2001-08-08 | 2002-07-29 | Therapeutic agent for depletion of an unwanted protein population from plasma |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1418905T3 true DK1418905T3 (da) | 2007-09-10 |
Family
ID=26246416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02751356T DK1418905T3 (da) | 2001-08-08 | 2002-07-29 | Terapeutisk middel til depletering af en uönsket proteinpopulation fra plasma |
Country Status (8)
Country | Link |
---|---|
US (2) | US7691897B2 (es) |
EP (1) | EP1418905B1 (es) |
JP (1) | JP4472333B2 (es) |
AT (1) | ATE361068T1 (es) |
DE (1) | DE60219926T2 (es) |
DK (1) | DK1418905T3 (es) |
ES (1) | ES2284895T3 (es) |
WO (1) | WO2003013508A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7390795B2 (en) | 2000-12-18 | 2008-06-24 | Pentraxin Therapeutics Limited | Treatment and prevention of tissue damage |
DE60219926T2 (de) | 2001-08-08 | 2007-11-22 | Pentraxin Therapeutics Ltd. | Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma |
GB0211136D0 (en) | 2002-05-15 | 2002-06-26 | Univ London | Treatment and prevention of tissue damage |
GB0313386D0 (en) | 2003-06-10 | 2003-07-16 | Univ London | Treatment of disease |
EP2139524A1 (en) * | 2007-03-23 | 2010-01-06 | The Governors of the University of Alberta | Multivalent heterobifunctional polymers and methods of their use |
GB0718718D0 (en) | 2007-09-25 | 2007-11-07 | Pentraxin Therapeutics Ltd | Compound and use thereof |
US9886546B2 (en) | 2012-11-20 | 2018-02-06 | General Electric Company | Methods and apparatus to label radiology images |
CA3026178C (en) * | 2016-06-29 | 2024-05-21 | The Scripps Research Institute | Diprovocims: a new and potent class of tlr agonists |
US20210315992A1 (en) * | 2018-08-02 | 2021-10-14 | The Board Of Regents Of The University Of Texas System | Adjuvant effect of the tlr1/2 agonist diprovocim synergizes with checkpoint-inhibiting antibodies to eliminate disease |
GB202014589D0 (en) | 2020-09-16 | 2020-10-28 | Ucl Business Ltd | Agents for use in the treatment of amyloidosis |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62277352A (ja) | 1986-01-30 | 1987-12-02 | Ono Pharmaceut Co Ltd | 新規な6−ケト−プロスタグランジンe1誘導体、それらの製造方法およびそれらを有効成分として含有する細胞障害治療剤 |
US4895872A (en) | 1989-03-15 | 1990-01-23 | Cetus Corporation | Immunosupressive analogues and derivatives of succinylacetone |
JPH0667472B2 (ja) * | 1988-11-28 | 1994-08-31 | 鐘淵化学工業株式会社 | 血清アミロイドp蛋白用吸着体 |
DE69434571T2 (de) * | 1993-03-29 | 2006-08-03 | Queen's University At Kingston, Kingston | Propan-1,3-disulphonsäure und deren pharmazeutisch akzeptable Salze zur Behandlung von Amyloidosis |
GB9317120D0 (en) | 1993-08-17 | 1993-09-29 | Royal Postgrad Med School | Human serum amyloid p component |
US6172045B1 (en) * | 1994-12-07 | 2001-01-09 | Neorx Corporation | Cluster clearing agents |
WO1998050420A1 (en) | 1997-05-02 | 1998-11-12 | Akzo Nobel N.V. | Serine protease inhibitors |
US6365570B1 (en) | 1997-10-10 | 2002-04-02 | Universiteit Utrecht | Pharmaceutical and diagnostic use of Serum Amyloid P component |
PT915088E (pt) | 1997-10-31 | 2003-01-31 | Hoffmann La Roche | Derivados de d-prolina |
GB0119370D0 (en) * | 2001-08-08 | 2001-10-03 | Univ London | Therapeutic agent |
DE60219926T2 (de) * | 2001-08-08 | 2007-11-22 | Pentraxin Therapeutics Ltd. | Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma |
GB0313386D0 (en) | 2003-06-10 | 2003-07-16 | Univ London | Treatment of disease |
-
2002
- 2002-07-29 DE DE60219926T patent/DE60219926T2/de not_active Expired - Lifetime
- 2002-07-29 JP JP2003518517A patent/JP4472333B2/ja not_active Expired - Fee Related
- 2002-07-29 DK DK02751356T patent/DK1418905T3/da active
- 2002-07-29 ES ES02751356T patent/ES2284895T3/es not_active Expired - Lifetime
- 2002-07-29 EP EP02751356A patent/EP1418905B1/en not_active Expired - Lifetime
- 2002-07-29 AT AT02751356T patent/ATE361068T1/de not_active IP Right Cessation
- 2002-07-29 WO PCT/GB2002/003504 patent/WO2003013508A1/en active IP Right Grant
-
2006
- 2006-01-17 US US11/332,312 patent/US7691897B2/en not_active Expired - Fee Related
-
2009
- 2009-03-16 US US12/404,840 patent/US8173694B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60219926T2 (de) | 2007-11-22 |
EP1418905A1 (en) | 2004-05-19 |
EP1418905B1 (en) | 2007-05-02 |
ES2284895T3 (es) | 2007-11-16 |
US8173694B2 (en) | 2012-05-08 |
US7691897B2 (en) | 2010-04-06 |
US20060122124A1 (en) | 2006-06-08 |
JP2005501071A (ja) | 2005-01-13 |
WO2003013508A1 (en) | 2003-02-20 |
DE60219926D1 (de) | 2007-06-14 |
ATE361068T1 (de) | 2007-05-15 |
US20100173969A1 (en) | 2010-07-08 |
JP4472333B2 (ja) | 2010-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL371736A1 (en) | Method for administering glp-1 molecules | |
CY1104988T1 (el) | Μεθοδος αντιμετωπισης μολυνσεων του μεσου ωτος | |
DK1487493T3 (da) | Konjugater af cytotoksiske midler og biologisk aktive peptider | |
EA200500218A1 (ru) | ЛЕЧЕНИЕ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ С ПРИМЕНЕНИЕМ ИНТЕРФЕРОНА-β | |
WO2008050148A3 (en) | Therapy for liver disease | |
DK1740197T3 (da) | Prolyl-endopeptidease (PEP) og glutamin-endoprotease til behandlingen af cøliaki | |
CY1111613T1 (el) | Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv | |
DE60239931D1 (de) | Kombinationstherapie | |
CY1111237T1 (el) | Χρηση πραμιπεξολης για αντιμετωπιση αμυοτροφικης πλευρικης σκληρυνσης | |
NO20053817D0 (no) | Preparater og fremgangsmater for antiviral kombinasjonsterapi. | |
NO20050427L (no) | Carvedilolfosfatsalter og/eller solvater derav, tilsvarende preparater og/eller behandlingsfremgangsmater | |
HUP0303917A2 (hu) | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére | |
DE60137337D1 (de) | Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene | |
DK1418905T3 (da) | Terapeutisk middel til depletering af en uönsket proteinpopulation fra plasma | |
ATE319439T1 (de) | Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd | |
IS7798A (is) | Efnasambönd, lyfjablöndur og aðferðir | |
HK1064950A1 (en) | Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) | |
MXPA04006572A (es) | Terapia de combinacion antivirica. | |
DE50313092D1 (de) | Mittel zur behandlung von flaviviridae-infektionen | |
DK1381382T3 (da) | Fremgangsmåder og præparater til behandling af öjensygdomme | |
NO20033506L (no) | Parasitticidale preparater og metoder for anvendelse | |
FR2845917B1 (fr) | Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire | |
DE60204224D1 (de) | Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen | |
DK1441761T3 (da) | Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr | |
DK1353948T3 (da) | Oplöselige biologiske analoge til bata-amyloidpeptid |